APA (7th ed.) Citation

SW, M., JR, T., SF, V., SI, L., R, S., A, P., . . . CC, C. (2003). Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: Synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides. Bioorganic & medicinal chemistry letters, 13(3), 567. https://doi.org/10.1016/s0960-894x(02)00918-6

Chicago Style (17th ed.) Citation

SW, McCombie, et al. "Piperazine-based CCR5 Antagonists as HIV-1 Inhibitors. III: Synthesis, Antiviral and Pharmacokinetic Profiles of Symmetrical Heteroaryl Carboxamides." Bioorganic & Medicinal Chemistry Letters 13, no. 3 (2003): 567. https://doi.org/10.1016/s0960-894x(02)00918-6.

MLA (9th ed.) Citation

SW, McCombie, et al. "Piperazine-based CCR5 Antagonists as HIV-1 Inhibitors. III: Synthesis, Antiviral and Pharmacokinetic Profiles of Symmetrical Heteroaryl Carboxamides." Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 3, 2003, p. 567, https://doi.org/10.1016/s0960-894x(02)00918-6.